Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SRRM3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
C16orf87 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GAS7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPCAM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZC3H6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MOS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TNFRSF18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DNAJB14 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPAG11A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RSBN1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HTR3C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TCEAL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HMGXB4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SMPD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPB41L2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AREL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC9C2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on